Oncosec Medical Stock Z Score
ONCSDelisted Stock | USD 0.06 0 3.63% |
OncoSec |
OncoSec Medical Company Z Score Analysis
OncoSec Medical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current OncoSec Medical Z Score | -23.08 |
Most of OncoSec Medical's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, OncoSec Medical has a Z Score of -23.08. This is 441.93% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
OncoSec Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoSec Medical's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics of similar companies.OncoSec Medical is currently under evaluation in z score category among its peers.
OncoSec Fundamentals
Return On Equity | -4.1 | |||
Return On Asset | -0.93 | |||
Current Valuation | 5.6 M | |||
Shares Outstanding | 5.96 M | |||
Shares Owned By Insiders | 28.01 % | |||
Shares Owned By Institutions | 5.83 % | |||
Number Of Shares Shorted | 192.06 K | |||
Price To Earning | (3.12) X | |||
Price To Book | 0.78 X | |||
EBITDA | (35.92 M) | |||
Net Income | (34.18 M) | |||
Cash And Equivalents | 19.48 M | |||
Cash Per Share | 0.50 X | |||
Total Debt | 6.17 M | |||
Debt To Equity | 0.76 % | |||
Current Ratio | 4.51 X | |||
Book Value Per Share | (1.85) X | |||
Cash Flow From Operations | (32.14 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (20.31) X | |||
Target Price | 110.0 | |||
Number Of Employees | 40 | |||
Beta | 2.0 | |||
Market Capitalization | 1.65 M | |||
Total Asset | 21.88 M | |||
Retained Earnings | (285.96 M) | |||
Working Capital | 8.6 M | |||
Current Asset | 29.42 M | |||
Current Liabilities | 3.47 M | |||
Z Score | -23.08 | |||
Net Asset | 21.88 M |
About OncoSec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |